2 Stocks That Could Soar This Year

In the volatile biotech industry, companies can see their shares soar over relatively short periods on strong clinical progress for exciting pipeline candidates.That’s precisely what could happen to Exelixis (NASDAQ: EXEL) and Summit Therapeutics (NASDAQ: SMMT) this year. And the even better news is that there are reasons to consider holding onto these drugmakers’ shares even beyond the next 12 months. Let’s find out more.Image source: Getty Images.Continue readinghttps://www.fool.com/investing/2026/01/31/2-stocks-that-could-soar-this-year/

more insights

I’ve been advising wealthy family offices on real estate for decades. This market requires another look at your 100-year plan

March 8, 2026

https://finance.yahoo.com/news/ve-advising-wealthy-family-offices-120000971.html

These Are the Top 5 Best Places to Retire

March 8, 2026

The Motley Fool conducted research on the U.S. counties where people want to retire.

SanDisk To Benefit From The AI-Driven Memory Squeeze As Prices Surge

March 8, 2026

https://seekingalpha.com/article/4879887-sandisk-to-benefit-from-ai-driven-memory-squeeze-as-prices-surge

Marius Grobler is an authorised representative and Key Individual of Trive South Africa (Pty) Ltd FSP 27231.
The content on this webiste should not be considered as advice.
© Marius Grobler 2025. All rights reserved. Powered by Social Revolution